Zhenping Chen (Z Chen, Yingzi Zhen)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Atrial Fibrillation

Hodgkin Lymphoma

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Research and practice in thrombosis and haemostasis

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Shuyue Dong, Zhifa Wang, Nan Wang, Jingyao Ma, Jinxi Meng, Zhenping Chen, Runhui Wu, Xiaoling Cheng
Exploratory study on the individualized application of eltrombopag in paediatric immune thrombocytopaenia guided by therapeutic drug monitoring. British journal of haematology (2024)
Tao Guan, Di Ai, Nan Zhao, Guoqing Liu, Wanru Yao, Zhenping Chen, Zhengping Li, Yaohan Zhou, Runhui Wu
Treatment-related outcome from patient report outcome (PRO) of children with severe and moderate hemophilia A in China: An analysis report of registration data from patient organization "hemophilia home care center". Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Huang Kun, Di Ai, Gang Li, Yingzi Zhen, Yan Wang, Ningning Zhang, Aihua Huo, Guoqing Liu, Zhenping Chen, Runhui Wu
Individualised prophylaxis based on personalised target trough FVIII level optimised clinical outcomes in paediatric patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 28 (6) (2022)
Jie Sun, Zekun Li, Huang Kun, Di Ai, Gang Li, Xingjuan Xie, Hao Gu, Guoqing Liu, Yingzi Zhen, Zhenping Chen, Runhui Wu
F8 gene mutation spectrum in severe hemophilia A with inhibitors: A large cohort data analysis from a single center in China. Research and practice in thrombosis and haemostasis 6 (4) (2022)
Jie Sun, Zekun Li, Gang Li, Huang Kun, Di Ai, Guoqing Liu, Wanru Yao, Xingjuan Xie, Hao Gu, Yingzi Zhen, Zhenping Chen, Runhui Wu
Low-dose immune tolerance induction in children with severe hemophilia A with high-titer inhibitors: Type of factor 8 mutation and outcomes. Research and practice in thrombosis and haemostasis 6 (7) (2022)
Huang Kun, Yingzi Zhen, Gang Li, Xinyi Wu, Zhenping Chen, Runhui Wu
Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia A after switching to Kovaltry from other standard half-life factor VIII concentrates. Research and practice in thrombosis and haemostasis 6 (2) (2022)
Zekun Li, Guoqing Liu, Wanru Yao, Zhenping Chen, Gang Li, Xiaoling Cheng, Yingzi Zhen, Di Ai, Huang Kun, Jie Sun, Man-Chiu Poon, Runhui Wu
Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in China. Haemophilia : the official journal of the World Federation of Hemophilia 28 (4) (2022)
Huang Kun, Zhenping Chen, Runhui Wu
"A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates": Comment from Huang et al. Journal of thrombosis and haemostasis : JTH 20 (10) (2022)
Runhui Wu, Xiaojing Li, Wanru Yao, Qing Zhang, Min Zhou, Ningning Zhang, Sheng Yang, Zhenping Chen, Yan Wang, Yangying Kuang, Ling Tang, Yingzi Zhen, Audrey Abad, Andrea S Doria, Pamela Hilliard, Danial M Ignas, Prasad Mathew, Derek Stephens, Victor S Blanchette, Koon-Hung Luke
Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low-dose secondary prophylaxis study. Research and practice in thrombosis and haemostasis 5 (6) (2021)
Zekun Li, Zhenping Chen, Guoqing Liu, Xiaoling Cheng, Wanru Yao, Huang Kun, Gang Li, Yingzi Zhen, Xinyi Wu, Siyu Cai, Man-Chiu Poon, Runhui Wu
Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors. Research and practice in thrombosis and haemostasis 5 (5) (2021)
Xiaoling Cheng, LingLing Fu, Jing-Yao Ma, Lingling Fu, Zhenping Chen, Li-Bo Zhao, Xiaoling Wang, Runhui Wu
Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice. Blood advances 5 (19) (2021)
Zekun Li, Guoqing Liu, Wanru Yao, Zhenping Chen, Gang Li, Xiaoling Cheng, Yingzi Zhen, Di Ai, Huang Kun, Man-Chiu Poon, Runhui Wu
Nephrotic syndrome in two haemophilia B children with inhibitor under low-dose immune tolerance induction combined with rituximab-based immunosuppressant protocol. Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2021)
Huang Kun, Yingzi Zhen, Gang Li, Xinyi Wu, Runhui Wu, Zhenping Chen
Pharmacokinetic study of Kovaltry in thirty-five pediatric patients aged <12 years with severe hemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Huang Kun, Gang Li, Yingzi Zhen, Xinyi Wu, Zhenping Chen, Runhui Wu
Comparative pharmacokinetics of Kogenate FS and Kovaltry in 14 Chinese paediatric patients with haemophilia A: A single-centre study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2020)
Zekun Li, Zhenping Chen, Xiaoling Cheng, Guoqing Liu, Xinyi Wu, Gang Li, Zhenping Chen, Siyu Cai, Man-Chiu Poon, Runhui Wu
A low-dose immune tolerance induction (ITI) protocol incorporating immunosuppressive agents in haemophilia A children with high-titre factor VIII inhibitor and poor-ITI prognostic risk. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2020)
Zekun Li, Zhenping Chen, Xiaoling Cheng, Xinyi Wu, Gang Li, Yingzi Zhen, Siyu Cai, Man-Chiu Poon, Runhui Wu
Low-dose immune tolerance induction for children with hemophilia A with poor-risk high-titer inhibitors: A pilot study in China. Research and practice in thrombosis and haemostasis 3 (4) (2019)
Xiaoling Cheng, P Li, Zhenping Chen, N Zhang, Y Zhen, L Zhao, X Wang, R Wu
Break-through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 24 (1) (2017)